Dupont A - Search Results

1

Serum prostate specific antigen as pre-screening test for prostate cancer.

Labrie F, Dupont A, Suburu R, Cusan L, Tremblay M, Gomez JL, Emond J. Labrie F, et al. Among authors: dupont a. J Urol. 1992 Mar;147(3 Pt 2):846-51; discussion 851-2. doi: 10.1016/s0022-5347(17)37402-5. J Urol. 1992. PMID: 1371560

2

Prostate specific antigen and prostatic acid phosphatase for monitoring therapy of carcinoma of the prostate.

Dupont A, Cusan L, Gomez JL, Thibeault MM, Tremblay M, Labrie F. Dupont A, et al. J Urol. 1991 Oct;146(4):1064-7; discussion 1067-8. doi: 10.1016/s0022-5347(17)38001-1. J Urol. 1991. PMID: 1716697

3

Optimized strategy for detection of early stage, curable prostate cancer: role of prescreening with prostate-specific antigen.

Labrie F, Dupont A, Suburu R, Cusan L, Gomez JL, Koutsilieris M, Diamond P, Emond J, Lemay M, Candas B. Labrie F, et al. Among authors: dupont a. Clin Invest Med. 1993 Dec;16(6):425-39. Clin Invest Med. 1993. PMID: 7516831 Clinical Trial.

4

Response to flutamide withdrawal in advanced prostate cancer in progression under combination therapy.

Dupont A, Gomez JL, Cusan L, Koutsilieris M, Labrie F. Dupont A, et al. J Urol. 1993 Sep;150(3):908-13. doi: 10.1016/s0022-5347(17)35646-x. J Urol. 1993. PMID: 7688437

5

Screening decreases prostate cancer death: first analysis of the 1988 Quebec prospective randomized controlled trial.

Labrie F, Candas B, Dupont A, Cusan L, Gomez JL, Suburu RE, Diamond P, Lévesque J, Belanger A. Labrie F, et al. Among authors: dupont a. Prostate. 1999 Feb 1;38(2):83-91. doi: 10.1002/(sici)1097-0045(19990201)38:2<83::aid-pros1>3.0.co;2-b. Prostate. 1999. PMID: 9973093 Clinical Trial.

6

Combination therapy with flutamide and medical (LHRH agonist) or surgical castration in advanced prostate cancer: 7-year clinical experience.

Labrie F, Dupont A, Cusan L, Gomez J, Emond J, Monfette G. Labrie F, et al. Among authors: dupont a. J Steroid Biochem Mol Biol. 1990 Dec 20;37(6):943-50. doi: 10.1016/0960-0760(90)90448-t. J Steroid Biochem Mol Biol. 1990. PMID: 2285608 Clinical Trial.

7

Combination therapy with flutamide and castration: its benefits at various stages of prostate cancer.

Labrie F, Dupont A, Cusan L, Manhès G, Bergeron N, Lacourcière Y, Pineault S, Bélanger A, Monfette G, Emond J. Labrie F, et al. Among authors: dupont a. Prog Clin Biol Res. 1989;303:161-7. Prog Clin Biol Res. 1989. PMID: 2674982 Review. No abstract available.

8

Combination therapy with castration and flutamide: today's treatment of choice for prostate cancer.

Labrie F, Dupont A, Cusan L, Manhès G, Bergeron N, Lacourcière Y, Pineault S, Bélanger A, Monfette G, Emond J. Labrie F, et al. Among authors: dupont a. J Steroid Biochem. 1989 Oct;33(4B):817-21. doi: 10.1016/0022-4731(89)90499-8. J Steroid Biochem. 1989. PMID: 2689788 Review.

9

Anti-hormone treatment for prostate cancer relapsing after treatment with flutamide and castration. Addition of aminoglutethimide and low dose hydrocortisone to combination therapy.

Labrie F, Dupont A, Bélanger A, Cusan L, Brochu M, Turina E, Pinault S, Lacourciere Y, Emond J. Labrie F, et al. Among authors: dupont a. Br J Urol. 1989 Jun;63(6):634-8. doi: 10.1111/j.1464-410x.1989.tb05260.x. Br J Urol. 1989. PMID: 2752257

10

Important prognostic value of standardized objective criteria of response in stage D2 prostatic carcinoma.

Labrie F, Dupont A, Giguere M, Cusan L, Bergeron N, Emond J, Monfette G, Lacourciere Y, Boucher H, Lachance R. Labrie F, et al. Among authors: dupont a. Eur J Cancer Clin Oncol. 1988 Dec;24(12):1869-78. doi: 10.1016/0277-5379(88)90100-9. Eur J Cancer Clin Oncol. 1988. PMID: 3220084

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,130 results

Search Page

Filters